Skip to main content

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.28
+2.01 (0.98%)
AAPL  273.62
+7.44 (2.80%)
AMD  211.47
+14.87 (7.56%)
BAC  50.07
-1.00 (-1.96%)
GOOG  308.00
-3.69 (-1.18%)
META  634.20
-3.05 (-0.48%)
MSFT  387.12
+2.65 (0.69%)
NVDA  191.54
-0.01 (-0.00%)
ORCL  145.44
+4.13 (2.92%)
TSLA  405.89
+6.06 (1.52%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.